CG
GMAB icon

Cutler Group’s Genmab GMAB Stock Holding History

Cutler Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$16K – 5923
2021
Q1 		$16K Buy
+10,000
New +$376K ﹤0.01% 3386
2020
Q4 		– Sell
-1,700
Closed -$17K – 5052
2020
Q3 		$17K Sell
1,700
-1,100
-39% -$39.8K ﹤0.01% 2572
2020
Q2 		$11K Buy
+2,800
New +$76.3K ﹤0.01% 2804

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cutler Group's GMAB Position: Q4 2021 in Review

Cutler Group sold out of Genmab (GMAB) in Q4 2021, closing a stake of 100 shares — an estimated $4K sold.

Cutler Group first reported a position in GMAB in Q3 2020 and held it in 4 quarters. The position peaked at $6K in Q1 2021. 211 funds tracked by Wall St. Rank hold GMAB as of Q4 2021.

  • Cutler Group reported no remaining Genmab position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 100 Genmab shares in Q4 2021, an estimated $4K.
  • Cutler Group first reported a position in Genmab in Q3 2020 and held it in 4 quarters.
  • Cutler Group's Genmab position peaked at $6K in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Genmab as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.